Pharmacokinetics, Pharmacodynamics and Clinical Use of SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
Year: 2015
Type: review
Source: Clinical Pharmacokinetics
Author: André J. Scheen
Institution: University of Liège
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: SGLT2 inhibitors, type 2 diabetes, chronic kidney disease, pharmacokinetics, pharmacodynamics, dapagliflozin, canagliflozin, empagliflozin, ipragliflozin, tofogliflozin, dose adjustment, glucuronidation, urinary glucose excretion, estimated glomerular filtration rate, diabetic nephropathy, renal function, drug safety
Open Access status: closed
OpenAlex ID: W2036936011
